![Mel Hayes](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mel Hayes
Corporate Officer/Principal presso FULCRUM THERAPEUTICS, INC.
Patrimonio netto: 52 422 $ in data 31/05/2024
Posizioni attive di Mel Hayes
Società | Posizione | Inizio | Fine |
---|---|---|---|
FULCRUM THERAPEUTICS, INC. | Corporate Officer/Principal | 02/10/2023 | - |
Direttore operativo | 09/08/2022 | 02/10/2023 |
Storia della carriera di Mel Hayes
Precedenti posizioni note di Mel Hayes
Società | Posizione | Inizio | Fine |
---|---|---|---|
BAXALTA INC | Corporate Officer/Principal | - | - |
Shire, Inc.
![]() Shire, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire, Inc. develops and markets medicines for patients with rare diseases. The company is based in Lexington, KY. | Vendite & Marketing | - | - |
Sanofi Ventures
![]() Sanofi Ventures Investment ManagersFinance Sanofi Ventures (Sanofi) is a venture capital subsidiary of Sanofi founded in 2001. The firm is headquartered in Cambridge, Massachusetts. | Corporate Officer/Principal | - | - |
BIOVERATIV INC | Corporate Officer/Principal | - | - |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Formazione di Mel Hayes
Southern Methodist University | Undergraduate Degree |
Columbia Business School | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 9 |
Posizioni
Corporate Officer/Principal | 5 |
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Settori
Health Technology | 6 |
Consumer Services | 3 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
FULCRUM THERAPEUTICS, INC. | Health Technology |
Aziende private | 5 |
---|---|
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Sanofi Ventures
![]() Sanofi Ventures Investment ManagersFinance Sanofi Ventures (Sanofi) is a venture capital subsidiary of Sanofi founded in 2001. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Bioverativ, Inc.
![]() Bioverativ, Inc. BiotechnologyHealth Technology Bioverativ, Inc. is a global biopharmaceutical company, focused on discovery, research, development and commercialization of therapies for the treatment of blood diseases including hemophilia. The company is headquartered in Cambridge, MA. | Health Technology |
Shire, Inc.
![]() Shire, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire, Inc. develops and markets medicines for patients with rare diseases. The company is based in Lexington, KY. | Health Technology |
Baxalta, Inc.
![]() Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
- Borsa valori
- Insiders
- Mel Hayes
- Esperienza